Objective: Although defense mechanisms are central concepts in psychiatry, whether individual disorders (or categories of disorders) are associated with a specific profile of defense mechanisms or whether defense mechanisms are general markers of severity of psychopathology is unknown.
Methods: We drew on data from the National Epidemiological Survey on Alcohol and Related Conditions (N = 43,093) to investigate associations of 12 pathological defense mechanisms with mood, anxiety, and substance use disorders. Logistic regressions were fit with mental disorders as predictors, defense mechanisms as outcomes, and respondent age, sex, and race/ethnicity as covariates.
Results: Compared to individuals with no disorders, those with mood, anxiety, or substance use disorders generally had a higher prevalence of defense mechanisms. Specifically, the prevalence of any pathological mechanism was 30.0% (95% CI, 29.4%–30.7%) for individuals with no disorders, 67.6% (95% CI, 65.9%–69.2%) for individuals with mood disorders, 62.8% (95% CI, 61.3%–64.2%) for individuals with anxiety disorders, and 49.8% (95% CI, 48.7%–51.0%) for individuals with substance use disorders. Broad diagnostic categories or individual psychiatric disorders were not associated with specific defense profiles.
Conclusion: Our findings suggest that defense mechanisms and psychiatric disorders represent correlated but different dimensions of psychopathology, which may respond to different treatment approaches.
J Clin Psychiatry 2025;86(2):24m15582
Author affiliations are listed at the end of this article.
Continue Reading...
Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Bond M, Perry JC. Long-term changes in defense styles with psychodynamic psychotherapy for depressive, anxiety, and personality disorders. Am J Psychiatry. 2004;161(9):1665–1671.
Vaillant GE. Theoretical hierarchy of adaptive ego mechanisms: a 30-year follow-up of 30 men selected for psychological health. Arch Gen Psychiatry. 1971;24(2):107–118.
Berney S, de Roten Y, Beretta V, et al. Identifying psychotic defenses in a clinical interview. J Clin Psychol. 2014;70(5):428–439.
Constantinides P, Beck SM. Toward developing a scale to empirically measure psychotic defense mechanisms. J Am Psychoanal Assoc. 2010;58(6):1159–1188.
Vaillant GE. Ego mechanisms of defense and personality psychopathology. J Abnorm Psychol. 1994;103(1):44–50.
Morey LC, Good EW, Hopwood CJ. Global personality dysfunction and the relationship of pathological and normal trait domains in the DSM-5 alternative model for personality disorders. J Pers. 2022;90(1):34–46.
Krueger RF, Hobbs KA. An overview of the DSM-5 alternative model of personality disorders. Psychopathology. 2020;53(3–4):126–132.
Blanco C, Kampe L, Wall MM, et al. Approximating defense mechanisms in a national study of adults: prevalence and correlates with functioning. Transl Psychiatry. 2023;13(1):21.
Huprich SK, Defife J, Westen D. Refining a complex diagnostic construct: subtyping dysthymia with the shedler-westen assessment procedure-II. J Affect Disord. 2014;152–154:186–192.
Powers A, Westen D. Personality subtypes in patients with panic disorder. Compr Psychiatry. 2009;50(2):164–172.
Mullen LS, Blanco C, Vaughan SC, et al. Defense mechanisms and personality in depression. Depress Anxiety. 1999;10(4):168–174.
Kipper L, Blaya C, Teruchkin B, et al. Evaluation of defense mechanisms in adult patients with panic disorder: before and after treatment. J Nerv Ment Dis. 2005;193(9):619–624.
Knijnik DZ, Salum GA Jr., Blanco C, et al. Defense style changes with the addition of psychodynamic group therapy to clonazepam in social anxiety disorder. J Nerv Ment Dis. 2009;197(7):547–551.
Blaya C, Dornelles M, Blaya R, et al. Do defense mechanisms vary according to the psychiatric disorder? Braz J Psychiatry. 2006;28(3):179–183.
Colovic O, Lecic Tosevski D, Perunicic Mladenovic I, et al. Defense mechanisms in “pure” anxiety and “pure” depressive disorders. J Nerv Ment Dis. 2016;204(10):746–751.
Bond MP, Vaillant JS. An empirical study of the relationship between diagnosis and defense style. Arch Gen Psychiatry. 1986;43(3):285–288.
Kampe L, Zimmermann J, Bender D, et al. Comparison of the structured DSM-5 clinical interview for the level of personality functioning scale with the structured interview of personality organization. J Pers Assess. 2018;100(6):642–649.
Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051–1066.
Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7–16.
Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37–44.
Hasin D, Carpenter KM, McCloud S, et al. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2–3):133–141.
Perry JC, Hoglend P, Shear K, et al. Field trial of a diagnostic axis for defense mechanisms for DSM-IV. J Pers Disord. 1998;12(1):56–68.
Perry JC, Metzger J, Sigal JJ. Defensive functioning among women with breast cancer and matched community controls. Psychiatry. 2015;78(2):156–169.
Kramer U, Despland JN, Michel L, et al. Change in defense mechanisms and coping over the course of short-term dynamic psychotherapy for adjustment disorder. J Clin Psychol. 2010;66(12):1232–1241.
Di Giuseppe M, Perry JC. The hierarchy of defense mechanisms: assessing defensive functioning with the defense mechanisms rating scales Q-sort. Front Psychol. 2021;12:718440.
Zimmerman M, Morgan TA, Stanton K. The severity of psychiatric disorders. World Psychiatry. 2018;17(3):258–275.
Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol. 2012;22(suppl 3):S499–S504.
Spinhoven P, Kooiman CG. Defense style in depressed and anxious psychiatric outpatients: an explorative study. J Nerv Ment Dis. 1997;185(2):87–94.
Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921–926.
Blanco C, Krueger RF, Hasin DS, et al. Mapping common psychiatric disorders: structure and predictive validity in the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2013;70(2):199–208.
Goodkind M, Eickhoff SB, Oathes DJ, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015;72(4):305–315.
Bowins B. How psychiatric treatments can enhance psychological defense mechanisms. Am J Psychoanal. 2006;66(2):173–194.
Mojtabai R, Olfson M. National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry. 2008;65(8):962–970.
Tadmon D, Olfson M. Trends in outpatient psychotherapy provision by U.S. Psychiatrists: 1996-2016. Am J Psychiatry. 2022;179(2):110–121.
Newby JM, Twomey C, Yuan Li SS, et al. Transdiagnostic computerised cognitive behavioural therapy for depression and anxiety: a systematic review and meta analysis. J Affect Disord. 2016;199:30–41.
Arbuckle MR, Travis MJ, Ross DA. Integrating a neuroscience perspective into clinical psychiatry today. JAMA Psychiatry. 2017;74(4):313–314.